214 related articles for article (PubMed ID: 11457595)
1. Altered content and modulation of soluble guanylate cyclase in the cerebellum of rats with portacaval anastomosis.
Monfort P; Corbalán R; Martinez L; López-Talavera J; Córdoba J; Felipo V
Neuroscience; 2001; 104(4):1119-25. PubMed ID: 11457595
[TBL] [Abstract][Full Text] [Related]
2. Chronic exposure to aluminium impairs the glutamate-nitric oxide-cyclic GMP pathway in the rat in vivo.
Hermenegildo C; Sáez R; Minoia C; Manzo L; Felipo V
Neurochem Int; 1999 Mar; 34(3):245-53. PubMed ID: 10355491
[TBL] [Abstract][Full Text] [Related]
3. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
Fedele E; Jin Y; Varnier G; Raiteri M
Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
[TBL] [Abstract][Full Text] [Related]
4. Alterations in soluble guanylate cyclase content and modulation by nitric oxide in liver disease.
Rodrigo R; Montoliu C; Chatauret N; Butterworth R; Behrends S; Del Olmo JA; Serra MA; Rodrigo JM; Erceg S; Felipo V
Neurochem Int; 2004 Nov; 45(6):947-53. PubMed ID: 15312989
[TBL] [Abstract][Full Text] [Related]
5. Chronic hyperammonemia in rats impairs activation of soluble guanylate cyclase in neurons and in lymphocytes: a putative peripheral marker for neurological alterations.
Miñana MD; Corbalán R; Montoliu C; Teng CM; Felipo V
Biochem Biophys Res Commun; 1999 Apr; 257(2):405-9. PubMed ID: 10198226
[TBL] [Abstract][Full Text] [Related]
6. Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo.
Hermenegildo C; Montoliu C; Llansola M; Muñoz MD; Gaztelu JM; Miñana MD; Felipo V
Eur J Neurosci; 1998 Oct; 10(10):3201-9. PubMed ID: 9786213
[TBL] [Abstract][Full Text] [Related]
7. Brain regional alterations in the modulation of the glutamate-nitric oxide-cGMP pathway in liver cirrhosis. Role of hyperammonemia and cell types involved.
Rodrigo R; Felipo V
Neurochem Int; 2006; 48(6-7):472-7. PubMed ID: 16517021
[TBL] [Abstract][Full Text] [Related]
8. Age-related changes in the NMDA receptor/nitric oxide/cGMP pathway in the hippocampus and cerebellum of freely moving rats subjected to transcerebral microdialysis.
Vallebuona F; Raiteri M
Eur J Neurosci; 1995 Apr; 7(4):694-701. PubMed ID: 7542528
[TBL] [Abstract][Full Text] [Related]
9. Altered modulation of soluble guanylate cyclase by nitric oxide in patients with liver disease.
Corbalán R; Montoliu C; Miñana MD; Del Olmo JA; Serra MA; Aparisi L; Rodrigo JM; Felipo V
Metab Brain Dis; 2002 Dec; 17(4):295-301. PubMed ID: 12602506
[TBL] [Abstract][Full Text] [Related]
10. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients.
Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Ferrandez A; Rodrigo JM; Felipo V
J Mol Med (Berl); 2007 Mar; 85(3):237-45. PubMed ID: 17216205
[TBL] [Abstract][Full Text] [Related]
11. Region selective alterations of soluble guanylate cyclase content and modulation in brain of cirrhotic patients.
Corbalán R; Chatauret N; Behrends S; Butterworth RF; Felipo V
Hepatology; 2002 Nov; 36(5):1155-62. PubMed ID: 12395325
[TBL] [Abstract][Full Text] [Related]
12. Release of arginine, glutamate and glutamine in the hippocampus of freely moving rats: Involvement of nitric oxide.
Watts J; Fowler L; Whitton PS; Pearce B
Brain Res Bull; 2005 May; 65(6):521-8. PubMed ID: 15862924
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Protein Kinase A Modulates Intracellular Calcium/Calmodulin-Dependent Protein Kinase II, Nitric Oxide Synthase, and the Glutamate-Nitric Oxide-cGMP Pathway in Cerebellum. Differential Effects in Hyperammonemia.
Cabrera-Pastor A; Llansola M; Felipo V
ACS Chem Neurosci; 2016 Dec; 7(12):1753-1759. PubMed ID: 27673574
[TBL] [Abstract][Full Text] [Related]
14. Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum. Effects of amyloid beta peptide.
Chalimoniuk M; Strosznajder JB
Mol Chem Neuropathol; 1998; 35(1-3):77-95. PubMed ID: 10343972
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide-evoked glutamate release and cGMP production in cerebellar slices: control by presynaptic 5-HT1D receptors.
Marcoli M; Cervetto C; Paluzzi P; Guarnieri S; Raiteri M; Maura G
Neurochem Int; 2006 Jul; 49(1):12-9. PubMed ID: 16469416
[TBL] [Abstract][Full Text] [Related]
16. Bile duct ligation plus hyperammonemia in rats reproduces the alterations in the modulation of soluble guanylate cyclase by nitric oxide in brain of cirrhotic patients.
Rodrigo R; Jover R; Candela A; Compañ A; Sáez-Valero J; Erceg S; Felipo V
Neuroscience; 2005; 130(2):435-43. PubMed ID: 15664700
[TBL] [Abstract][Full Text] [Related]
17. Hyperammonemia alters the modulation by different neurosteroids of the glutamate-nitric oxide-cyclic GMP pathway through NMDA- GABAA - or sigma receptors in cerebellum in vivo.
González-Usano A; Cauli O; Agustí A; Felipo V
J Neurochem; 2013 Apr; 125(1):133-43. PubMed ID: 23227932
[TBL] [Abstract][Full Text] [Related]
18. Activation of spinal N-methyl-D-aspartate receptors stimulates a nitric oxide/cyclic guanosine 3,5-monophosphate/glutamate release cascade in nociceptive signaling.
Kawamata T; Omote K
Anesthesiology; 1999 Nov; 91(5):1415-24. PubMed ID: 10551594
[TBL] [Abstract][Full Text] [Related]
19. Functional localization of soluble guanylate cyclase in turtle retina: modulation of cGMP by nitric oxide donors.
Blute TA; Velasco P; Eldred WD
Vis Neurosci; 1998; 15(3):485-98. PubMed ID: 9685201
[TBL] [Abstract][Full Text] [Related]
20. Differential modulation of the glutamate-nitric oxide-cyclic GMP pathway by distinct neurosteroids in cerebellum in vivo.
Cauli O; González-Usano A; Agustí A; Felipo V
Neuroscience; 2011 Sep; 190():27-36. PubMed ID: 21703332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
